Skip to main content
Syfovre 15 mg/.1mL injection, solution by Apellis Pharmaceuticals, Inc.
Syfovre, 15 mg/.1mL, injection, solution Drug class: Complement Inhibitor. Available on prescription only. Listed by Apellis Pharmaceuticals, Inc..
Prescription only

Syfovre

Pegcetacoplan

Listed by Apellis Pharmaceuticals, Inc.

Strength
15 mg/.1mL
Form
Injection, Solution
Route
Intravitreal
Class
Complement Inhibitor

What it contains

  • Pegcetacoplan 15 mg/.1mL

FDA record

Dosage form Injection, Solution
Route Intravitreal
Drug class Complement Inhibitor
Approval route NDA — original brand approval
NDC code 73606-020
FDA application NDA217171
RxNorm concept 2630847
Package sizes listed 4
Marketed since February 2023

Other products containing Pegcetacoplan

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Empaveli

Pegcetacoplan

Strength
1080 mg/20mL
Form
Injection, Solution
Class
Complement Inhibitor
Rx only

Apellis Pharmaceuticals, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.